I graduated with a degree in pharmacy from the University of Baghdad in 1999 and then work as lab instructor in the Department of clinical laboratory sciences of the same institution .in 2002 I begin my master study and completed in 2006 in the specialty of Clinical Biochemistry also from the same institution .My master thesis was about osteoarthritis .in 2013 I get the degree of lecturer ,then on 2016 I begin my Ph.D. study in the same institution and completed in 2020 ,my thesis about new tumor markers of breast cancer .I still work in the College of pharmacy/university of Baghdad at clinical laboratory sciences department
master degree in pharmacy in 2006 from college of oharmacy / Ph.D in clinical chemistry in 2020 from college of pharmacy/university of baghdad
1.member of committee of of examination in 2023-2024 2.member of committee of of examination in 2006-2007 3.member of committee of of examination in 2014-2015
i am intrested in studying the clinical aspects concerning breast cancer including recent tumor markers ,also studying the role of interleuks in breast cancer
teaching :clinical chemistry ,training in clinical laboratory ,biochemistry
clinical chemistry clinical laboratory training biology
i had 10 puplished papers,and supervised 3 master students and 2 diplome students in the speciality of clinical chemistry
Toxoplasmosis is regarded as one of the most important global life-threatening diseases in immune-compromised people. The intracellular protozoon Toxoplasma gondii is the causative pathogen of toxoplasmosis. Aim of this study is to investigate the possible association between T. gondii infection and breast cancer (BC) in Iraqi women, also to assess the effect of T. gondiion interleukin 10 (IL-10) of the immune response. By ELISA method, blood samples from 81 women with breast cancer and 60 apparently healthy women have been examined for presence of anti-toxoplasmaantibodies, also the levels of serum IL-10 were estimated in these subjects. Results showed that women with BC had the highest prevalence rate of toxoplasmosis. The anti- T.gondii
... Show More
Breast cancer (BC) is the most commonly diagnosed cancer in women. The metabolism of iron is closely regulated by hepcidin which exerts its action by interacting with a ferroportin.
The aim of the present study was to assess the alterations in the levels of some serum biomarkers that have a role in iron homeostasis (hepcidin and ferroportin) in addition to hematological parameters (hemoglobin, leukocyte and platelets count) in different stages of BC.
This study included 66 women with BC. The patients were categorized as follows : group 1 includes :22 patients with stage I disease ,group 2 includes: 22 patients with stage II disease ,and group 3 include: 22 patients with stage III disease .Group 4 includes :22 appare
... Show More
(4)
(2)
Abstract Background: Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. Identifying novel biomarkers is critical for improving diagnosis, prognosis, and treatment strategies. This study investigates the serum levels of kisspeptin-1 (KISS1), its receptor (KISS1R), growth differentiation factor 15 (GDF15), and carcinoembryonic antigen (CEA) in Iraqi CRC patients. Objectives: Explore associations between serum levels of Kiss1, Kiss1R, GDF, and CEA and disease progression in Iraqi patients with CRC. Methods: A case-control study was conducted, including 72 CRC patients and 36 healthy controls. Patients were stratified into non-metastatic and metastatic groups. Serum biomarker levels were measured using enzyme-link
... Show More